VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Kao Corporation vs Novartis AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Kao Corporation
4452 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Kao Corporation's moat claims, evidence, and risks.
View 4452 analysisNovartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisComparison highlights
- Moat score gap: Novartis AG leads (65 / 100 vs 60 / 100 for Kao Corporation).
- Segment focus: Kao Corporation has 5 segments (33.5% in Hygiene Living Care Business); Novartis AG has 5 segments (29.3% in Oncology).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Kao Corporation has 5 moat types across 2 domains; Novartis AG has 4 across 3.
Primary market context
Kao Corporation
Hygiene Living Care Business
Household & fabric care and sanitary consumer packaged goods
Japan and Asia (with select global brands)
Consumers (retail)
Branded manufacturer
33.5%
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Side-by-side metrics
Moat coverage
Shared moat types
Kao Corporation strengths
Novartis AG strengths
Segment mix
Kao Corporation segments
Full profile >Hygiene Living Care Business
Oligopoly
Health Beauty Care Business
Competitive
Cosmetics Business
Competitive
Business Connected Business
Competitive
Chemical Business
Competitive
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.